Oculogica
Curated by SignalEye tracking technology to detect traumatic brain injury (TBI)
Overview
Oculogica provides eye-tracking technology that detects proper brain functioning. Oculogica’s EyeBox CNS is authorized by the FDA as an aid in the diagnosis of concussion. Its technology detects weaknesses of the specific cranial nerves that move the eye, and the signature of palsies in any given patient informs regarding the location and nature of their pathology. Its solution requires no baseline data or individual calibration, so the results cannot be influenced by a patient's will. It has 4 patents and 3 working papers.
Key facts
- Founded
- 2013
- Headquarters
- New York City, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 1 product or service
- Sign up to view
Contact
- Primary office
- Sign up to view